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A bs tr ac t
Background
For patients with large abdominal aortic aneurysms, randomized trials have shown 
an initial overall survival benefit for elective endovascular repair over conventional 
open repair. This survival difference, however, was no longer significant in the sec-
ond year after the procedure. Information regarding the comparative outcome more 
than 2 years after surgery is important for clinical decision making.
Methods
We conducted a long-term, multicenter, randomized, controlled trial comparing open 
repair with endovascular repair in 351 patients with an abdominal aortic aneurysm 
of at least 5 cm in diameter who were considered suitable candidates for both tech-
niques. The primary outcomes were rates of death from any cause and reinterven-
tion. Survival was calculated with the use of Kaplan–Meier methods on an intention-
to-treat basis.
Results
We randomly assigned 178 patients to undergo open repair and 173 to undergo en-
dovascular repair. Six years after randomization, the cumulative survival rates were 
69.9% for open repair and 68.9% for endovascular repair (difference, 1.0 percentage 
point; 95% confidence interval [CI], −8.8 to 10.8; P = 0.97). The cumulative rates of 
freedom from secondary interventions were 81.9% for open repair and 70.4% for 
endovascular repair (difference, 11.5 percentage points; 95% CI, 2.0 to 21.0; P = 0.03).
Conclusions
Six years after randomization, endovascular and open repair of abdominal aortic aneu-
rysm resulted in similar rates of survival. The rate of secondary interventions was sig-
nificantly higher for endovascular repair. (ClinicalTrials.gov number, NCT00421330.)
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Randomized trials have shown that endovascular repair offers a perioperative survival benefit over open repair for pa-
tients with a large abdominal aortic aneurysm. 
However, this advantage is not sustained beyond 
2 years after surgery.1-4 There is concern that en-
dovascular repair lacks durability, with the pos-
sibility of an increased risk of late rupture,5 and 
that more reinterventions are required in patients 
undergoing this technique. Long-term outcome 
data from these trials are considered to be of cru-
cial importance in deciding which treatment op-
tion a patient should be offered.6,7 To date, only 
limited data beyond 2 years after randomization 
have been reported. To provide long-term data, 
we analyzed the results of the Dutch Randomized 
Endovascular Aneurysm Repair (DREAM) trial af-
ter a median of 6.4 years.1,3
Me thods
Study Design
The design and methods of this trial have been de-
scribed in detail previously.8 In brief, the DREAM 
trial was a multicenter, randomized trial conduct-
ed at 26 centers in the Netherlands and 4 centers 
in Belgium. The institutional review board at each 
center approved the original trial protocol and the 
follow-up extension. The study was performed ac-
cording to the principles of the Declaration of Hel-
sinki.
The trial was funded by a grant from the Neth-
erlands National Health Insurance Council. No 
support was provided by pharmaceutical or med-
ical-device companies. The sponsor had no role in 
the design or conduct of the study; in the collec-
tion, management, analysis, or interpretation of 
the data; or in the preparation, review, or approval 
of the manuscript.
Study Patients
Patients who had an abdominal aortic aneurysm 
measuring at least 5 cm in diameter and who were 
considered suitable candidates for either open or 
endovascular repair were enrolled after providing 
written informed consent. Suitability for endovas-
cular repair was primarily determined by means 
of endograft-dependent anatomical criteria, where-
as suitability for open repair was determined by an 
internist or cardiologist. Patients who required 
emergency aneurysm repair were excluded from 
the trial, as were patients with inflammatory an-
eurysms, anatomical variations (e.g., horseshoe 
kidney), connective-tissue disease, a history of or-
gan transplantation, or a life expectancy of less 
than 2 years.
Randomization to either procedure was carried 
out centrally with the use of a computer-generat-
ed, permuted-block sequence and stratified ac-
cording to study center in blocks of four patients. 
The primary informed consent covered 2 years of 
close follow-up for all patients. For this long-term 
analysis, a second written informed consent was 
requested from all patients who had completed the 
initial 2 years of follow-up. Patients were asked to 
provide consent for continued acquisition of fol-
low-up data for the purpose of this study and for 
our sending twice-yearly questionnaires on their 
quality of life and use of medical services. Pa-
tients were informed that the follow-up protocol 
after the second postoperative year would not 
require extra studies for trial purposes and would 
involve only the collection of data regarding rou-
tine clinical care.
Data Collection and Follow-up
Follow-up visits for the initial phase of the trial 
were scheduled 30 days and 6, 12, 18, and 24 
months after the procedure. After the initial 2 years 
of close follow-up, patients received a question-
naire every 6 months requesting information about 
the status of their mental and physical health, as 
well as information about visits to a general prac-
titioner or other physicians and all hospital ad-
missions. Follow-up for patients in the endovas-
cular-repair group included a yearly follow-up visit 
and the performance of computed tomography 
(CT). Patients in the open-repair group were ad-
vised to see their physicians annually, but they were 
not actively recruited for follow-up visits during the 
third and fourth years after surgery. All patients 
were contacted by telephone 5 years postopera-
tively and were invited for a follow-up visit with a 
CT scan. Medical records were used to confirm the 
information that patients had provided. All data 
were submitted to the trial-coordination center 
at the Julius Center for Health Sciences and Pri-
mary Care, University Medical Center, Utrecht, the 
Netherlands.
For the current analysis, data acquisition was 
stopped on February 1, 2009. For all analyses, data 
were censored after the last follow-up contact or 
at the time the last questionnaire was returned. 
Patients who had declined further participation 
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at 2 years or who were initially lost to follow-up 
were contacted directly or through their relatives 
or physicians. In addition, from November 2008 
through February 2009, all records were scruti-
nized for information about reinterventions and 
causes of death. The information obtained in 
this way was incorporated into the analysis of 
crude survival and causes of death.
Primary Outcomes
The long-term primary outcomes were rates of 
death from any cause and reintervention. An out-
come-adjudication committee, consisting of five 
vascular surgeons, classified the causes of death 
and reinterventions in a blinded fashion and in-
dependently from one another. Disagreements 
were resolved in a plenary consensus meeting.
The causes and exact dates of death were 
determined by reviewing death certificates and, 
if necessary, by contacting the involved physi-
cians (general practitioners, surgeons, and other 
specialists) and patients’ relatives. In-hospital 
death was defined as any death occurring within 
30 days after the original procedure or any death 
occurring more than 30 days after the original 
procedure but during the same hospital admis-
sion. We distinguished between cardiovascular 
causes of death (myocardial infarction, congestive 
heart failure, cardiac arrest, stroke, and ruptured 
aneurysm) and noncardiovascular causes of death 
(cancer, pulmonary conditions, and miscella-
neous disorders).
A reintervention was defined as any surgical 
or endovascular procedure that was related to the 
primary aneurysm-repair procedure. The decision 
to perform a secondary intervention was made 
by the individual surgeon. Indications for reinter-
ventions were classified into three groups: graft-
related indications (e.g., thrombo-occlusive dis-
ease, endoleak type 1 or endotension [pressure 
in the aneurysm sac without a detectable endo-
leak], endograft migration, prosthesis infection, 
graft-material failure, para-anastomotic aneurysm, 
and aneurysm rupture), wound-related indications 
(e.g., incisional hernia and wound infection), and 
local or system ic indications (e.g., bleeding, endo-
leak type 2, and ileus).
Statistical Analysis
All data were analyzed according to the inten-
tion-to-treat principle. The completeness of fol-
low-up was calculated as the ratio of the total 
observed person-time of follow-up to the poten-
tial time of follow-up in the study for the two 
study groups.9 Kaplan–Meier analysis was used 
to calculate survival and other end points, and 
differences between groups were compared with 
the use of the log-rank test. All reported P values 
are two-sided and have not been corrected for 
multiple testing.
R esult s
Study Patients
From November 2000 through December 2003, 
we randomly assigned 178 patients to undergo 
open repair and 173 to undergo endovascular re-
pair (Fig. 1). Baseline characteristics are shown 
in Table 1. The mean age of the patients was 70 
years, and 91.7% were male; 43.9% had concom-
itant cardiac disease.
Six patients did not undergo aneurysm repair 
after randomization: four declined treatment 
(three in the open-repair group and one in the 
endovascular-repair group), one died from a rup-
tured abdominal aortic aneurysm before under-
going open repair, and one died from pneumo-
nia before undergoing endovascular repair. There 
were eight in-hospital deaths after open repair 
and two after endovascular repair (Fig. 1).
The median follow-up was 6.4 years (range, 
5.1 to 8.2). All patients were followed for 5 years, 
79% for 6 years, and 53% for 7 years. The com-
pleteness of follow-up was 99.3% (11,589/11,673 
months) for open repair and 99.7% (11,193/11,232 
months) for endovascular repair. At the date of 
censoring, 106 patients had died during follow-
up after hospital discharge (51 in the open-repair 
group and 55 in the endovascular-repair group) 
(Fig. 1). Five years after randomization, CT was 
performed in approximately one fourth of pa-
tients in the open-repair group and in almost all 
patients in the endovascular-repair group.
Overall Survival
Six years after randomization, the cumulative 
overall survival rates were 69.9% for open repair 
and 68.9% for endovascular repair, for a differ-
ence of 1.0 percentage point (95% confidence 
interval [CI], −8.8 to 10.8; P = 0.97) (Fig. 2A). The 
increased perioperative mortality in the open-
repair group was counterbalanced by a larger 
number of deaths after discharge in the endovas-
cular-repair group. An analysis of the causes of 
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death indicated that miscellaneous rather than car-
diovascular causes accounted for the larger num-
ber of deaths after discharge among patients 
undergoing endovascular repair (Table 2).
Reintervention
Six years after randomization, the cumulative rates 
of freedom from secondary interventions were 
81.9% for open repair and 70.4% for endovascular 
repair, for a difference of 11.5 percentage points 
(95% CI, 2.0 to 21.0; P = 0.03) (Fig. 2B). After open 
repair, the most frequent reintervention was cor-
rection of an abdominal incisional hernia, whereas 
endovascular-repair reinterventions were most of-
ten performed because of endograft-related com-
plications, such as endoleak and endograft mi-
gration (Table 3). In one patient who had crossed 
over from open to endovascular repair, reinterven-
tion because of an occluded endograft limb was 
complicated by a fatal myocardial infarction.
In the open-repair group, nine patients required 
a second reintervention and two required a third 
reintervention. After endovascular repair, 14 pa-
tients required a second reintervention, and 7 re-
quired a third reintervention. Endovascular proce-
dures accounted for 5 of 41 reinterventions (12%) 
in the open-repair group and 25 of 69 reinterven-
tions (36%) in the endovascular-repair group.
Discussion
Our principal finding was that among patients 
with large abdominal aortic aneurysms, there was 
no significant difference between endovascular 
repair and open repair in the rate of overall sur-
vival at a median of 6.4 years. A small but signifi-
351 Patients underwent randomization
(November 2000–December 2003)
178 Were assigned to undergo
open repair
173 Were assigned to undergo
endovascular repair
4 Did not undergo assigned
 repair
3 Declined to participate
1 Died
8 Died in hospital
2 Did not undergo assigned
repair
1 Declined to participate
1 Died
174 Started aneurysm repair
167 Completed open repair
4 Completed endovascular repair
1 Aborted endovascular repair
171 Started aneurysm repair
167 Completed endovascular repair
1 Completed open repair
3 Had immediate conversion
to open repair
166 Were discharged from hospital
161 After open repair
4 After endovascular repair
1 After no repair
169 Were discharged from hospital
165 After endovascular repair
4 After open repair
2 Died in hospital
51 Died
115 Were still alive in February 2009 114 Were still alive in February 2009
55 Died
Figure 1. Enrollment and Outcomes.
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cant difference in 30-day operative mortality in 
favor of endovascular repair had previously been 
reported in the DREAM trial and in two large, 
randomized trials.1,2,10 In 2-year analyses of both 
the DREAM trial3 and the United Kingdom Endo-
vascular Aneurysm Repair 1 (EVAR 1) trial (Cur-
rent Controlled Trials number, ISRCTN55703451),4 
this apparent early benefit had already been lost. 
With the longer follow-up in our study, the rate 
of overall survival remained similar for the two 
procedures.
Another finding was that endovascular repair 
was associated with a significantly higher rate of 
reintervention than was open repair. This obser-
vation supports the view that the short-term 
survival benefit of endovascular repair is achieved 
at the expense of long-term problems related to 
endograft durability. Although these problems 
do not seem to translate into a long-term disad-
vantage in overall survival, the risks associated 
with reintervention need to be assessed in larger 
studies. It is important to recognize that reinter-
Table 1. Baseline Characteristics of the Patients.*
Characteristic
Open Repair
(N = 178)
Endovascular Repair
(N = 173) P Value
Age — yr 69.6±6.8 70.7±6.6 0.13
Male sex — no. (%) 161 (90.4) 161 (93.1) 0.44
Patients with mild, moderate, or severe SVS/ISCVS 
risk-factor score — %†
Diabetes mellitus 9.6 10.4 0.86
Tobacco use 55.1 64.2 0.10
Hypertension 54.5 58.4 0.52
Hyperlipidemia 52.6 47.0 0.33
Carotid disease 15.2 14.5 0.88
Cardiac disease 46.6 41.0 0.33
Renal disease 8.4 7.5 0.85
Pulmonary disease 18.5 27.7 0.04
Sum of SVS/ISCVS risk-factor scores 4.5±2.5 4.4±2.5 0.61
FEV1 — liters/sec 2.6±0.7 2.5±0.7 0.27
Body-mass index 26.6±4.1 26.3±3.4 0.47
ASA class — no. (%)
I (healthy) 44 (24.7) 37 (21.4) 0.53
II (mild systemic disease) 110 (61.8) 122 (70.5) 0.09
III (severe systemic disease) 24 (13.5) 14 (8.1) 0.12
Medication use — no. (%)
Beta-blocker 92 (51.7) 76 (43.9) 0.17
Statin‡ 72 (41.9) 63 (37.3) 0.44
Antiplatelet agent 72 (40.4) 70 (40.5) 1.00
Angiotensin-converting–enzyme inhibitor 50 (28.1) 58 (33.5) 0.30
Calcium-channel blocker 32 (18.0) 30 (17.3) 0.89
Anticoagulant 27 (15.2) 20 (11.6) 0.35
* Plus–minus values are means ±SD. ASA denotes American Society of Anesthesiologists, and FEV1 forced expiratory vol-
ume in 1 second. The body-mass index is the weight in kilograms divided by the square of the height in meters. Because 
of rounding, not all percentages total 100.
† The Society for Vascular Surgery/International Society for Cardiovascular Surgery (SVS/ISCVS) risk-factor score ranges 
from 0 (no risk factors) to 3 (severe risk factors) for each of eight domains.7 Total scores range from 0 to 24, with high-
er scores indicating more risk factors.
‡ No data about statin use were available for six patients in the open-repair group and four patients in the endovascular-
repair group.
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vention rates constitute a soft end point because 
the decision to perform a secondary procedure 
was at the discretion of the surgeon. However, 
the decisions of vascular surgeons in clinical 
practice are probably made on a similar basis.
In 2005, investigators in the EVAR 1 trial report-
ed a follow-up of 4 years for patients undergo-
ing either open repair or endovascular repair.4 
At that interval, however, the number of patients 
at risk had dropped below 20% of those who 
had undergone randomization, and fewer than 
half the patients had been followed for 3 years 
or more. The recently published Open Versus En-
dovascular Repair (OVER) trial (ClinicalTrials 
.gov number, NCT00094575) reported 2 years 
of follow-up on 80% of randomized patients but 
no 3-year results.10 However, problems arising 
from limited durability of endovascular aneu-
rysm repair are not expected to occur in the first 
2 postoperative years. In our analysis of the 
DREAM trial data, not a single patient was lost 
to follow-up, and all surviving patients were fol-
lowed for at least 5 years after randomization.
Retrospective hospital- and population-based 
studies with 9 years of follow-up after surgery 
have shown similar results.11-14 However, since 
these studies were not randomized, they all have 
a potential selection bias. The most important 
cause of bias is the potential association between 
the estimated short-term and long-term risks of 
death for a given patient, on the one hand, and 
the decision of the clinician to recommend open 
or endovascular repair, on the other.
In theory, inferior durability of endovascular 
repair, as compared with open repair, could 
mitigate long-term survival outcomes and there-
by negate the short-term survival benefit of 
endovascular repair or even result in increased 
long-term risk. The cluster of reinterventions 
that appeared in the fifth year after endovascu-
lar repair is particularly troubling and casts 
doubt on the durability of endovascular devices. 
In our study, reinterventions that were per-
formed more than 4 years after aneurysm repair 
were required because of endograft migration, 
limb thrombosis, or endoleak (type 1 or 2). The 
reintervention for an endograft limb occlusion 
followed by death a few days later illustrates the 
potential for reintervention to decrease patients’ 
quality of life and increase the risk of aneurysm-
related death.
Despite this concern, graft-related complica-
tions and aneurysm rupture were not frequent 
causes of death in the long term. Therefore, we 
could detect no effect of graft complications on 
survival, a finding that may be a consequence 
of insufficient statistical power. Long-term and 
pooled analyses of the four randomized trials 
— DREAM, EVAR 1, OVER, and Anévrisme de 
L’aorte Abdominale: Chirurgie versus Endopro-
thèse (ACE)15 — could have enough power to 
address this issue. However, it is also important 
to note that since the initiation of these trials, 
endovascular devices and techniques have un-
dergone further modification, and with increas-
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ing experience, physicians have revised their 
criteria for identifying suitable candidates for 
endovascular repair. These changes may reduce 
the risk of complications requiring reinterven-
tion and thus increase long-term survival after 
endovascular repair.
Some limitations of our study should be noted. 
Because patients in the open-repair group did 
not undergo CT in the third and fourth years 
after aneurysm repair, and because only about 
one fourth of patients in the open-repair group 
underwent CT at 5 years (as compared with 
almost all patients in the endovascular-repair 
group), ascertainment bias probably contributed 
to the finding of more graft-related problems in 
the endovascular-repair group. Conversely, since 
it is not common practice to follow patients for 
more than 6 to 12 months after open repair, the 
elaborate follow-up protocol for all patients in 
the DREAM trial during the first 2 postoperative 
years may have led to an artificially high rate of 
early reintervention after open repair.
Another limitation of our trial concerns the 
relatively wide confidence interval for the differ-
ence in the primary outcome. On the basis of 
this interval, our results are consistent with a 
survival rate in the open-repair group that is as 
much as 10.8% higher or 8.8% lower than that 
in the endovascular-repair group. This impreci-
sion is the inevitable consequence of the initial 
sample size and the numbers of patients re-
maining alive after 6 years of follow-up.
Not all patients with an abdominal aortic 
aneurysm are anatomically suitable for endovas-
cular repair. Certain subgroups of patients (in 
terms of expected survival, coexisting illnesses, 
or various associated risk factors) may benefit 
more from one or the other type of aneurysm 
repair, but much larger trials or analysis of 
pooled data from the existing trials would be 
needed to identify these patients. Nevertheless, 
our study may help guide physicians and pa-
tients in choosing between open and endovascu-
lar repair, since our findings can be appraised in 
relation to various individual and personal cir-
cumstances.
In conclusion, our comparison of endovascu-
lar repair of abdominal aortic aneurysm with 
open repair showed similar long-term survival 
6 years after randomization. There was a higher 
rate of secondary interventions in the endovas-
cular-repair group.
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